AI Karyotyping
NEW & IMPROVED Chromosome Analysis & Karyotyping Artificial Intelligence solution
Unraveling the Benefits of Computer-Aided Digital Pathology
This blog highlights the significant impact of AI in transforming anatomic pathology.
This field is witnessing a revolutionary transformation, thanks to digitalization and, more recently, to the advent of Artificial Intelligence (AI).
New algorithms based computer-aided chromosome analysis and karyotyping – a pilot evaluation – Abstract
The high accuracy of the new aided karyotyping is anticipated to reduce the time spent on preparing karyograms, allowing to focus more time on chromosome analysis and reporting.
The diagnostic utility of routine cytogenetic analysis in detecting MECOM rearrangements
Identifying MECOM rearrangements is critical to the diagnosis, classification, and risk stratification of myeloid malignancies. In this Webinar, Dr. Lori Ramkissoon and Will Coward will provide an overview of MECOM rearrangements in myeloid malignancies.
Barco and Applied Spectral Imaging (ASI) announce commercial partnership in digital pathology
Global visualization leader Barco and Applied Spectral Imaging (ASI), a world leader in advanced biomedical imaging, today announce a new commercial partnership to offer best-in-class digital solutions for pathology laboratories.
Motic Digital Pathology and Applied Spectral Imaging (ASI) Announce First Projects in Joint-Venture
Motic Digital Pathology and Applied Spectral Imaging (ASI) Announce First Projects in Joint-Venture to Create Integrated Digital Pathology Workflows for IHC and FISH Imaging through Validation with CorePath Laboratories.
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response
Inactivating TP53 mutations leads to a loss of function of p53, but can also often result in oncogenic gain-of-function (GOF) of mutant p53 proteins which promotes tumor development and progression.
Hexavalent Chromium Targets Securin to Drive Numerical Chromosome Instability in Human Lung Cells
Hexavalent chromium is a known human lung carcinogen with widespread exposure in environmental and occupational settings.
Happy New Year 2024
Warm winter greetings & Best wishes for the coming year Wishing you Happiness and Success over this Joyful season.
Thank you for your support and goodwill throughout the year.
Best wishes for a Merry Christmas
and a fantastic New Year
ASI’s collaboration with the CytoCell® division of OGT
We are thrilled to announce our collaboration with the CytoCell® division of OGT, a Sysmex Group company and a global leader in diagnostic genomic solutions! This partnership expands our global reach and adds value to customers in Cytogenetics laboratories.